AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15112871
Drug: Cefazolin 1
RxNorm normalized name: cefazolin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 1 gr. i.v. preoperative and at 8 hrs postoperative (2 doses) followed by nitrofurantoin 100 mg. oral every night until catheter removal.
Trial: 29092739
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron (200 mg elemental iron/day)
Trial: 22066459
Drug: Shenmai injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenmai injection (0.6 mL x kg(‐1) and physiological saline 100 mL)
Trial: 22066459
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (equal volume to Shenmai injection)
Trial: 19628730
Drug: 1 spray
RxNorm normalized name: Hygiene 1 Spray Wash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 spray of 1.7% estradiol transdermal spray (1.53 mg/spray) once daily for 14 days
Trial: 19628730
Drug: 2 sprays
RxNorm normalized name: fentanyl 1,200 mcg (600 mcg/spray, 2 sprays) SUBLINGUAL SPRAY, NON-AEROSOL (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 sprays of 1.7% estradiol transdermal spray (1.53 mg/spray) once daily for 14 days
Trial: 19628730
Drug: 3 sprays
RxNorm normalized name: tetracaine/benzocaine/butamben 2 %-14 %-2 % (200 mg/3 sprays) TOPICAL AEROSOL, METERED SPRAY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 sprays of 1.7% estradiol transdermal spray (1.53 mg/spray) once daily for 14 days
Trial: 17019520
Drug: Maxmarvil (calcitriol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxmarvil (calcitriol 0.5 mug and alendronate 5 mg)
Trial: 10949718
Drug: Actarit treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actarit treatment for 24 weeks in group I (stages I and II)
Trial: 10949718
Drug: Actarit treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actarit treatment for 24 weeks in group II (stages III and IV)
Trial: 10949718
Drug: Actarit treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actarit treatment in group I
Trial: 10949718
Drug: Actarit treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actarit treatment in group II
Trial: 8767154
Drug: Heparin calcine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin calcine
Trial: 1351053
Drug: Oral repeat‐action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral repeat‐action albuterol sulfate (Proventil Repetabs), 4 mg in the morning and 4‐16 mg at bedtime
Trial: 4096741
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nifedipine retard-tablet (Pidilat retard)
Trial: 4096741
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nifedipine retard-tablet (marketed formulation)
Trial: 24989685
Drug: Gadolinium injection
RxNorm normalized name: gadolinium
DrugBank: Gadolinium (DB12091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gadolinium injection (0.2 mmol/kg)
Trial: 2334616
Drug: Bupivacaine 2
RxNorm normalized name: bupivacaine 29.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2 mg kg‐1
Trial: 2334616
Drug: Bupivacaine 2
RxNorm normalized name: bupivacaine 29.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2 mg kg‐1 with adrenaline 1:200,000
Trial: 26145190
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of tranexamic acid (TXA) 3 g plus diluted epinephrine (DEP) 0.25 mg
Trial: 26145190
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of tranexamic acid (TXA) 3 g alone
Trial: 23307164
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 10 ml
Trial: 21930354
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone spray for 26 weeks
Trial: 18281145
Drug: 10mg vardenafil
RxNorm normalized name: vardenafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10mg vardenafil twice daily
Trial: 2691477
Drug: Amoxycillin/clavulanate (iv
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin/clavulanate (iv 100 mg/kg/day followed by oral 50 mg/kg/day)
Trial: 2691477
Drug: Benzylpenicillin (100,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzylpenicillin (100,000 IU/kg/day) + netilmicin (5 mg/kg/day) + metronidazole (30 mg/kg/day) (iv followed by oral metronidazole 30 mg/kg/day)
Trial: 30802200
Drug: Ertugliflozin 2.5
RxNorm normalized name: ertugliflozin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertugliflozin 2.5 mg BID
Trial: 30802200
Drug: Ertugliflozin 7.5
RxNorm normalized name: ertugliflozin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertugliflozin 7.5 mg BID
Trial: 396660
Drug: i.v. pirenzepine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. pirenzepine infusion (16 mg plus 2 mg/h for 2 hours)
Trial: 29619965
Drug: HIV-infected women
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-infected women receiving curative chemoradiation therapy (CRT)
Trial: 29619965
Drug: HIV-uninfected women
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-uninfected women receiving curative chemoradiation therapy (CRT)
Trial: 24720679
Drug: ABT‐450/r-ombitasvir and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT‐450/r-ombitasvir and dasabuvir with ribavirin (150 mg of ABT‐450, 100 mg of ritonavir, 25 mg of ombitasvir, 250 mg dasabuvir twice daily, and 1000 or 1200 mg ribavirin daily)
Trial: 22948032
Drug: Monovo® Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovo® Cream (new formulation of mometasone furoate with 33% water content)
Trial: 22948032
Drug: Ecural® Fettcreme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ecural® Fettcreme (commercially available fatty cream of mometasone furoate)
Trial: 9619531
Drug: Alpha‐methyl‐para‐tyrosine (AMPT),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha‐methyl‐para‐tyrosine (AMPT), 5 x 1 g doses over 26 hours
Trial: 9619531
Drug: Promethazine (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine (active placebo), 5 x 50 mg doses over 26 hours
Trial: 7663867
Drug: PCA morphine
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA morphine plus tenoxicam (20 mg, i.v.)
Trial: 31319484
Drug: I2 (5
RxNorm normalized name: Iodine-125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I2 (5 mg/day) before surgery for 7-35 days
Trial: 23984806
Drug: Canrenone 50
RxNorm normalized name: canrenone
DrugBank: Canrenone (DB12221)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canrenone 50 mg/day for 3 months, then 50 mg b.i.d. until the end of the study
Trial: 17092457
Drug: Pediatric constraint‐induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pediatric constraint‐induced therapy involving constraint of the functional upper extremity and intensive therapy with the hemiparetic upper extremity
Trial: 17092457
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical and occupational therapy
Trial: 8408933
Drug: Intravenous salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous salbutamol (10 micrograms/kg)
Trial: 8408933
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (100 micrograms, twice)
Trial: 29237386
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ω‐3 fatty acids and nano‐curcumin
Trial: 21047922
Drug: Intralipid/heparin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid/heparin infusion with 1 mU/min · kg euglycemic insulin clamp
Trial: 18496366
Drug: Insulin-mediated euglycemia
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-mediated euglycemia (mean blood glucose, 5.8 +/- 0.4 mmol/L)
Trial: 18496366
Drug: Moderate hyperglycemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate hyperglycemia (mean blood glucose, 9.6 +/- 0.6 mmol/L)
Trial: 17042842
Drug: Intravenous granisetron
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous granisetron 1 mg
Trial: 11129548
Drug: Spironolactone 50
RxNorm normalized name: spironolactone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 50 mg plus dexamethasone 0.5 mg (then 0.25 mg)
Trial: 24630685
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard PCa therapy alone)
Trial: 16533451
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 800 mug
Trial: 8340625
Drug: Buccal approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal approach with surgical bur
Trial: 3519731
Drug: Streptokinase therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase therapy (combined intravenous and intracoronary)
Trial: 3519731
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard coronary care unit treatment)
Trial: 27174526
Drug: Edaravone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone (60 mg/d) administered from the day of surgery to postsurgical day 7
Trial: 27174526
Drug: Edaravone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edaravone (60 mg/d)
Trial: 22414705
Drug: Propranolol (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (a beta adrenergic antagonist)
Trial: 19941990
Drug: CDA1 (10mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDA1 (10mg/kg intravenous infusion)
Trial: 12594635
Drug: Lipid formulation
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid formulation of amphotericin B (L‐AmB), 10 mg/kg daily for 2 days
Trial: 12594635
Drug: Lipid formulation
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid formulation of amphotericin B (L‐AmB), 4 mg/kg daily for 5 days
Trial: 10556145
Drug: Gentamicin 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 160 mg via dry powder inhaler (DPI)
Trial: 10556145
Drug: Gentamicin at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin at 5 mg/kg by intravenous infusion
Trial: 8737325
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (0.25 g creatine monohydrate per kg body mass)
Trial: 29651970
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg per day)
Trial: 25567010
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (HepB) administered on 0-1-6 schedule
Trial: 25567010
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (after first-dose revaccination)
Trial: 25567010
Drug: Anti-HBc alone
RxNorm normalized name: Aminosyn-HBC 7 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-HBc alone (after first-dose revaccination)
Trial: 25567010
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (after third-dose revaccination)
Trial: 25567010
Drug: Anti-HBc alone
RxNorm normalized name: Aminosyn-HBC 7 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-HBc alone (after third-dose revaccination)
Trial: 22873342
Drug: Aloe vera
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera gruel (30-40 mL daily)
Trial: 20415082
Drug: Traction (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traction (5 to 6 kg, 20 minutes each time, once every other day) and Nimodipine (40 mg, 3 times a day for 3 weeks)
Trial: 17903344
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of 600 mg
Trial: 17903344
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of 1200 mg
Trial: 17903344
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of 0 mg (control)
Trial: 10487455
Drug: Topical nystatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nystatin cream
Trial: 1465747
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (200 micrograms, one puff twice daily)
Trial: 29369159
Drug: Tox+ for
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tox+ for stimulants (methamphetamine or cocaine)
Trial: 29369159
Drug: Tox+ for
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tox+ for stimulants
Trial: 22222478
Drug: Skilled manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skilled manual control of propofol and remifentanil using target-controlled-infusion systems
Trial: 16217721
Drug: Speech Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Speech Therapy Assessment (STA)
Trial: 12017395
Drug: Enteric-coated diclofenac
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enteric-coated diclofenac sodium 50 mg (3 doses of 50 mg every 8 hours)
Trial: 2142700
Drug: 2.0 mg
RxNorm normalized name: LORAZEPAM 2.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg dexamethasone
Trial: 16321619
Drug: Oral alfentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral alfentanil (23, 30, 43, or 75 microg/kg)
Trial: 11986452
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam plus oral transmucosal fentanyl (5-10 microg/kg)
Trial: 11986452
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam plus placebo
Trial: 11986452
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam plus oral transmucosal fentanyl
Trial: 9535154
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg urapidil orally
Trial: 2761587
Drug: Aspirin (1300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1300 mg daily)
Trial: 28445631
Drug: CBT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT with Exposure Therapy (CBT/Exposure)
Trial: 28445631
Drug: CBT without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBT without Exposure Therapy (CBT)
Trial: 26081486
Drug: Sucrose-sweetened soft
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose-sweetened soft drinks (SSSDs) - 1 l daily for 6 months
Trial: 26081486
Drug: Isocaloric semi-skimmed
RxNorm normalized name: skim milk
DrugBank: Skim milk (DB15546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isocaloric semi-skimmed milk - 1 l daily for 6 months
Trial: 26081486
Drug: Diet cola
RxNorm normalized name: cola extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet cola - 1 l daily for 6 months
Trial: 26081486
Drug: Water -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water - 1 l daily for 6 months
Trial: 15338971
Drug: 81 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 81 mg/day aspirin
Trial: 15338971
Drug: 325 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 325 mg/day aspirin
Trial: 15338971
Drug: baseline (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: baseline (no aspirin)
Trial: 11341854
Drug: naloxone/lofexidine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naloxone/lofexidine combination treatment
Trial: 11341854
Drug: lofexidine monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lofexidine monotherapy
Trial: 8216441
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg/d
Trial: 28895379
Drug: Remifentanil at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil at a target effect‐site concentration of 7 ng×mL‐1
Trial: 23942318
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (MT) plus treatment as usual (TAU)
Trial: 17764606
Drug: Free iron/folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free iron/folic acid tablets (treatment, n = 109)
Trial: 17764606
Drug: Prescription to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription to purchase iron/folic acid tablets (control, n = 112)
Trial: 11411812
Drug: Sertraline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline treatment during the 24-week open-label continuation phase
Trial: 9827122
Drug: Local solution
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local solution based on 'pain de singe' (baobab fruit)
Trial: 9827122
Drug: WHO standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHO standard solution
Trial: 8314474
Drug: 3 million
RxNorm normalized name: INTERFERON GAMMA-1B 3 MILLION UNT/0.5ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 million units (MU) interferon three times weekly for six months
Trial: 8314474
Drug: 3 MU
RxNorm normalized name: Orasep Reformulated Dec 2013 Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 MU interferon three times weekly for the first six months, 2 MU for the next three months, and 1 MU for the last three months
Trial: 8314474
Drug: Longer treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Longer treatment (12 months)
Trial: 8314474
Drug: Shorter treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter treatment (6 months)
Trial: 3555164
Drug: bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine plus 1 ml normal saline (Group I)
Trial: 3555164
Drug: bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine plus 0.2 mg epinephrine (Group II)
Trial: 3555164
Drug: bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine plus 0.15 mg clonidine (Group III)
Trial: 30007057
Drug: Pregabalin 300
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300 mg orally 2 hours before surgery and 150 mg at 12 and 24 hours after surgery
Trial: 21562755
Drug: Prednisolone 30
RxNorm normalized name: prednisolone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 30 mg once daily
Trial: 21562755
Drug: Prednisolone 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 7.5 mg once daily
Trial: 22972030
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (plasma insulin 200 pmol/l)
Trial: 22972030
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (plasma insulin 600 pmol/l)
Trial: 19819661
Drug: Modified smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified smoking cessation treatment for depressive smokers
Trial: 19819661
Drug: Modified smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified smoking cessation treatment for higher dependence smokers
Trial: 17211088
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg monthly ibandronate
Trial: 17211088
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg bi‐monthly ibandronate
Trial: 15911865
Drug: Cisplatin 50
RxNorm normalized name: cisplatin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 50 mg/m(2) every 3 weeks (CPT)
Trial: 15911865
Drug: Cisplatin 50
RxNorm normalized name: cisplatin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 50 mg/m(2) day 1 plus topotecan 0.75 mg/m(2) days 1 to 3 every 3 weeks (CT)
Trial: 12479047
Drug: Epristeride 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epristeride 5 mg p.o., twice daily for 120 days
Trial: 2533526
Drug: Nafarelin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafarelin (200 micrograms twice daily intranasally for 3 or 6 months)
Trial: 6359
Drug: Cimetidine 25
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine 25 mg